Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Vivek Subbiah
Dec 11, 2023, 11:15 |
Blog
Vivek Subbiah: Precision Medicine - This is how we eradicate cancer as we know it
Vivek Subbiah shared on X/Twitter: "The best breast cancer clinical trial research strategy team in…
Dec 9, 2023, 17:16 |
Insight
Vivek Subbiah: Finding the genomic fusion needles in the haystacks via Liquid Biopsy Precision Medicine
Vivek Subbiah, shared a post by Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine and New…
Dec 7, 2023, 19:14 |
Blog
Vivek Subbiah: Delighted to meet with the rising young oncology star from Brazil, Juliana Beal!
Vivek Subbiah shared a post on his X/Twitter page: "Such a delight to meet with…
Dec 6, 2023, 15:38 |
Insight
Vivek Subbiah: Terrific review out in Cancer Discovery
Vivek Subbiah shared on LinkedIn: "Terrific review out in Cancer Discovery. Tumor evolution is fueled…
Dec 6, 2023, 11:43 |
Insight
Vivek Subbiah: Excited and honored to attend the San Antonio Breast Conference meeting
Vivek Subbiah shared on LinkedIn: "Excited and honored to attend the San Antonio Breast Conference…
Dec 5, 2023, 19:35 |
Blog
Vivek Subbiah: Cancer Evolution: A Multifaceted Affair! An amazing review
Vivek Subbiah made the following post on Twitter: "Cancer Evolution: A Multifaceted Affair! An amazing…
Dec 4, 2023, 15:54 |
Blog
Vivek Subbiah: Tissue-agnostic precision medicine takes the spotlight!
Vivek Subbiah shared a post on his LinkedIn page: "Hot off the press- Friday Motivation!…
Nov 29, 2023, 16:31 |
Drugs
Vivek Subbiah: Our review on management of FGFR inhibitor toxicities
Vivek Subbiah shared on LinkedIn: "Pleased to share our review on management of FGFR inhibitor…
Nov 28, 2023, 16:43 |
Drugs
Vivek Subbiah: Pleased to share our review on RET inhibitors
Vivek Subbiah shared on LinkedIn: "Pleased to share our review on RET inhibitors and RET inhibitor…
Nov 27, 2023, 17:17 |
Insight
Vivek Subbiah: Treatment patterns and overall survival (OS) in patients with advanced NSCLC in three countries between 2011 and 2020
Vivek Subbiah shared on LinkedIn: “Pleased to share our paper in American Cancer Society journal…
16
17
18
19
20
All:
284
Posts:
171 - 180
Matti Aapro is running for the UICC Board of Directors
CityU-AFCR Symposium on Precision Medicine and Digital Medicine
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
Facebook
RSS Feed
Twitter
Linkedin
Youtube